After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Immunome Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Immunome Inc is $963.22M. A total of 0.68 million shares were traded on the day, compared to an average of 1.02M shares.
In the most recent transaction, BIENAIME JEAN JACQUES bought 5,000 shares of IMNM for 9.38 per share on Jun 03 ’25. After the transaction, the Director now owns 36,415 company shares. In a previous transaction on Mar 25 ’25, BIENAIME JEAN JACQUES bought 7,800 shares at 7.78 per share. IMNM shares that Director owns now total 31,415.
Among the insiders who bought shares, SIEGALL CLAY B acquired of 137,100 shares on Mar 26 ’25 at a per-share price of $7.29. This resulted in the President and CEO holding 806,736 shares of IMNM after the transaction. In another insider transaction, BIENAIME JEAN JACQUES bought 7,000 shares at $8.21 per share on Mar 24 ’25. Company shares held by the Director now total 23,615.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, IMNM has a high of $16.81 and a low of $5.15.
As of this writing, IMNM has an earnings estimate of -$0.5 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.35 per share and a lower estimate of -$0.59.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. IMNM’s latest balance sheet shows that the firm has $49.23M in Cash & Short Term Investments as of fiscal 2021. There were $317.00k in debt and $9.73M in liabilities at the time. Its Book Value Per Share was $3.53, while its Total Shareholder’s Equity was $48.19M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IMNM is Buy with a score of 5.00.
